XML 19 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity
9 Months Ended
Sep. 30, 2017
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
(3) Stockholders' Equity
Dividends
On October 10, 2017, our board of directors declared a dividend of $0.32 per share of common stock. This dividend is to be paid in cash on November 22, 2017 to shareholders of record at the close of business on October 25, 2017. Since 2011, we have paid quarterly dividends. Our board of directors expects to continue paying quarterly dividends, provided the future determination as to payment of dividends will depend on the financial needs of the Company and such other factors as deemed relevant by the board of directors.
The following table presents the dividends either paid previously or declared by our board of directors for future payment on a per share basis:
 
2017
 
2016
First quarter
$
0.32

 
0.30

Second quarter
0.32

 
0.30

Third quarter
0.32

 
0.30

Fourth quarter
0.32

 
0.30

Total
$
1.28

 
1.20


Stock Options
The following tables summarize the details of options granted under our stock option plan that were still outstanding as of September 30, 2017, and the assumptions used to value these grants. All such grants were effective at the close of business on the date of grant.
 
Options
Granted
 
Option
Exercise
(Strike)
Price
 
Closing
Stock Price
on Date
of Grant
 
September 30, 2017
Date of Grant
 
 
 
Options
Outstanding
 
Options
Exercisable
January 3, 2017
764,789

 
$
47.00

 
$
46.95

 
725,542

 

April 19, 2016
845,440

 
$
46.00

 
$
45.74

 
757,522

 

April 21, 2015
893,220

 
$
42.00

 
$
41.26

 
700,746

 

April 22, 2014
955,000

 
$
56.00

 
$
50.53

 
572,500

 
116,250

April 16, 2013
205,000

 
$
54.00

 
$
49.25

 
104,250

 
57,250

April 17, 2012
1,235,000

 
$
54.00

 
$
49.01

 
957,938

 
776,103

April 19, 2011
410,000

 
$
35.00

 
$
31.78

 
72,550

 
47,550

April 20, 2010
530,000

 
$
30.00

 
$
27.13

 
107,800

 
82,800

April 21, 2009
790,000

 
$
27.00

 
$
17.61

 
221,650

 
221,650

Total
6,628,449

 
 
 
 
 
4,220,498

 
1,301,603


Date of Grant
Risk-free
Interest Rate
 
Expected Life of
Option in Years
 
Expected
Dividend
Yield
 
Expected
Stock
Volatility
 
Estimated Fair
Value of Stock
Option
January 3, 2017
1.9
%
 
5.00
 
2.6
%
 
24.49
%
 
$
8.40

April 19, 2016
1.3
%
 
5.00
 
2.6
%
 
26.34
%
 
$
8.18

April 21, 2015
1.3
%
 
5.00
 
2.7
%
 
26.84
%
 
$
7.35

April 22, 2014
1.8
%
 
5.00
 
2.0
%
 
28.55
%
 
$
9.57

April 16, 2013
0.7
%
 
5.00
 
1.6
%
 
37.42
%
 
$
12.66

April 17, 2012
0.9
%
 
5.00
 
1.4
%
 
39.25
%
 
$
13.69

April 19, 2011
2.1
%
 
5.00
 
1.6
%
 
39.33
%
 
$
11.20

April 20, 2010
2.6
%
 
5.00
 
1.5
%
 
39.10
%
 
$
8.14

April 21, 2009
1.9
%
 
5.00
 
1.0
%
 
38.80
%
 
$
3.64


All of the options in the tables above vest and become exercisable over a period of up to eight years. Generally, each option will terminate approximately nine years after the grant date.
 
The fair value of each share-based option is estimated on the date of grant using a Black-Scholes valuation method that uses the assumptions listed above. The risk-free interest rate is based on the U.S. Treasury rate over the expected life of the option at the time of grant. The expected life is the average length of time over which we expect the employee groups will exercise their options, which is based on historical experience with similar grants. The dividend yield is estimated over the expected life of the option based on our current dividend payout, historical dividends paid, and expected future cash dividends. Expected stock volatilities are based on the movement of our stock price over the most recent historical period equivalent to the expected life of the option.
Compensation expense equal to the grant date fair value is recognized for all of these awards over the vesting period. The stock-based compensation expense for the nine-month periods ended September 30, 2017 and 2016 was $4.0 and $2.9, respectively. Unrecognized stock-based compensation expense related to outstanding unvested stock options as of September 30, 2017 was $15.9 and is expected to be recognized over a weighted average period of 4.37 years. Any future changes in estimated forfeitures will impact this amount.
Earnings Per Share
The following tables present a reconciliation of the denominators used in the computation of basic and diluted earnings per share and a summary of the options to purchase shares of common stock which were excluded from the diluted earnings per share calculation because they were anti-dilutive:
 
Nine-month Period
 
Three-month Period
Reconciliation
2017
 
2016
 
2017
 
2016
Basic weighted average shares outstanding
288,451,470

 
288,907,934

 
287,456,943

 
288,995,492

Weighted shares assumed upon exercise of stock options
140,104

 
227,908

 
121,100

 
154,114

Diluted weighted average shares outstanding
288,591,574

 
289,135,842

 
287,578,043

 
289,149,606


 
 
Nine-month Period
 
Three-month Period
Summary of Anti-dilutive Options Excluded
2017
 
2016
 
2017
 
2016
Options to purchase shares of common stock
3,881,605

 
3,061,217

 
3,848,126

 
3,335,439

Weighted average exercise price of options
$
49.21

 
50.17

 
$
49.18

 
49.67


Any dilutive impact summarized above related to periods when the average market price of our stock exceeded the exercise price of the potentially dilutive stock options then outstanding.